Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $8.7300 (-6.23%) ($8.7300 - $8.7300) on Fri. Mar. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.46% (three month average) | RSI | 39 | Latest Price | $8.7300(-6.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -2.1% a day on average for past five trading days. | Weekly Trend | TGTX declines -4.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(77%) ARKG(72%) IBB(69%) ARKK(66%) IBUY(61%) | Factors Impacting TGTX price | TGTX will decline at least -3.73% in a week (0% probabilities). VIXM(-48%) VXX(-39%) UUP(-25%) TBT(-13%) EDOC(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.73% (StdDev 7.46%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-1.18(-113.52%) | Resistance Level | $10.17 | 5 Day Moving Average | $9.73(-10.28%) | 10 Day Moving Average | $9.8(-10.92%) | 20 Day Moving Average | $10.17(-14.16%) | To recent high | -57.3% | To recent low | 3% | Market Cap | $1.106b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |